Skip to content

Dermata Therapeutics

4 viewers · 30d

Total raised

$6.7M

3 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $4.1M
ROUNDS
3
INVESTORS
7
FOUNDED
2021
HQ
San Diego, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of innovative treatments for a range of skin diseases and aesthetic conditions. By leveraging both mechanical and chemical mechanisms, Dermata aims to deliver more effective solutions for dermatologic issues, including acne, psoriasis, and rosacea.

What sets it apart

Dermata stands out due to its novel approach that simultaneously utilizes mechanical and chemical mechanisms to address various dermatological conditions, enhancing treatment efficacy.

Funding history

3 rounds
Equity+2Dec 29, 2025
Form D
+$4.1M$6.7M total
Equity+2Jan 21, 2025
Form D
+$2.5M$2.5M total
Equity+2Jan 21, 2025
Form D/A
+$2.5M$2.5M total

Products

1 tracked

Dermatology Pipeline

Dermatology treatments

Dermata Therapeutics is developing a range of dermatology products derived from natural technologies, targeting dermatologic conditions through a combination of mechanical and chemical actions.

  • Combination of mechanical and chemical mechanisms
  • Focus on naturally derived technologies
  • Applicable to multiple dermatologic conditions